UiPath Inc <PATH.N>: Truist Securities cuts target price to $14 from $17
PATH•Related News

Myseum.AI seeks regulatory approval to tokenize Nasdaq-listed common stock
MYSE•

Oracle hosts Health and Life Sciences Summit online
ORCL•

Wave Life Sciences Initiates Phase 2A Combination Trial Of WVE-007 (GalNAc-siRNA) With Tirzepatide For Obesity
WVE•

General Mills beats quarterly results estimates on resilient demand for pantry staples
GIS•

Adagio Medical Announces Strategic Review Process To Maximize Shareholder Value
ADGM•